# Ivermectin Solution Bioequivalence Study - Fasted

> **NCT00921154** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Consumer and Personal Products Worldwide** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ivermectin

## Key facts

- **NCT ID:** NCT00921154
- **Lead sponsor:** Johnson & Johnson Consumer and Personal Products Worldwide
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921154, "Ivermectin Solution Bioequivalence Study - Fasted". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00921154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*